Marquina M, España A, Fernández-Galar M, López-Zabalza M J
Department of Dermatology, University Clinic of Navarra, School of Medicine, University of Navarra, PO 4209, Pamplona 31080, Spain.
Br J Dermatol. 2008 Jul;159(1):68-76. doi: 10.1111/j.1365-2133.2008.08582.x. Epub 2008 Jul 1.
Pemphigus vulgaris (PV) is a blistering autoimmune disease characterized by IgG autoantibodies against desmoglein 3. Nitric oxide synthases (NOS) may contribute to the increase of inflammation in tissues by the generation of nitrotyrosine residues (NTR).
To investigate whether the production of NTR mediated by NOS may participate in the development of inflammation and acantholysis in PV.
Mice were pretreated or not with NOS, tyrosine-kinase (TK) or nuclear factor (NF)-kappaB inhibitors, and then injected with PV-IgG. PV manifestations were examined in all mice. The expression of NTR, constitutive NOS (cNOS) [endothelial NOS (eNOS) and neuronal NOS (nNOS)], inducible NOS (iNOS) and NF-kappaB factor were studied in epidermis of mice using immunohistochemical techniques.
After PV-IgG injection, expressions of NTR, iNOS, eNOS and nNOS increased in acantholytic cells, as did nuclear translocation of NF-kappaB in the basal cells of the epidermis. Pretreatment of mice with inhibitors of TK, nNOS and nonselective NOS, completely prevented NTR expression and the clinical and histological findings of PV in mice. TK inhibitor genistein inhibited both nNOS and iNOS expression on the membrane of basal keratinocytes, and nuclear translocation of NF-kappaB.
Upregulation of cNOS and iNOS, NTR generation and nuclear translocation of NF-kappaB may contribute to increased inflammation and tissue damage in PV lesions. The absence of the clinical and histological findings of PV and NTR expression in mice injected with PV-IgG, through pretreatment with TK and nNOS inhibitors, provides compelling evidence that these signalling molecules should be considered as potential therapeutic targets in PV.
寻常型天疱疮(PV)是一种以针对桥粒芯糖蛋白3的IgG自身抗体为特征的水疱性自身免疫性疾病。一氧化氮合酶(NOS)可能通过生成硝基酪氨酸残基(NTR)促进组织炎症反应增强。
研究由NOS介导的NTR生成是否参与PV炎症反应及棘层松解的发生发展。
用NOS、酪氨酸激酶(TK)或核因子(NF)-κB抑制剂预处理小鼠,随后注射PV-IgG。观察所有小鼠的PV表现。采用免疫组化技术研究小鼠表皮中NTR、组成型NOS(cNOS)[内皮型NOS(eNOS)和神经元型NOS(nNOS)]、诱导型NOS(iNOS)及NF-κB因子的表达。
注射PV-IgG后,棘层松解细胞中NTR、iNOS、eNOS和nNOS的表达增加,表皮基底细胞中NF-κB的核转位也增加。用TK、nNOS和非选择性NOS抑制剂预处理小鼠,可完全阻止NTR表达以及小鼠PV的临床和组织学表现。TK抑制剂染料木黄酮可抑制基底角质形成细胞膜上的nNOS和iNOS表达以及NF-κB的核转位。
cNOS和iNOS上调、NTR生成及NF-κB核转位可能导致PV皮损炎症反应增强和组织损伤。通过用TK和nNOS抑制剂预处理,注射PV-IgG的小鼠未出现PV的临床和组织学表现及NTR表达,这提供了有力证据,表明这些信号分子应被视为PV潜在的治疗靶点。